Biotech Values

[ThomasS]

VRTX: "He added that from further analysis of the data, "it is now clear that telaprevir, not ribavirin, was the cause of the rash observed in combination treated patients in PROVE-1.""

---Interesting; my personal experience involved living out of hydrocortisone tubes due to Ribavirin... not to mention the severe ribavirin-induced anemia. They need to separate rashes by drug fractions.
The story remains the same: it would be nice for an improved "treatment," yet, the first effective vaccine will put all of these HCV companies on the ropes. IMO.